The Future of the Diabetes Care Devices Market to 2016 -The Key Demand Drivers Remain Intact

GBI Research’s new report, “The Future of the Diabetes Care Devices Market to 2016 - The Key Demand Drivers Remain Intact” provides key data, information and analysis on the global diabetes care devices market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on two diabetes care devices market categories - glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

• Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
• Global Market size and company share data for three diabetes care devices market categories – glucose monitoring and insulin delivery.
• Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
• Qualitative analysis of key market trends, market drivers and restraints by categories and segments.
• Competitive landscape and key company profiles. Key players covered include Roche, LifeScan, Bayer, Abbott, Becton, Dickinson, Medtronic, Novo Nordisk, Sanofi-Aventis, Eli Lilly, ARKRAY, Terumo, Animas and Smiths Medical.
• Key in-pipeline products and technologies expected to hit the global diabetes care devices market in the near future.

Reasons to buy

• Develop business strategies by understanding the trends and developments that are driving the diabetes care devices market globally.
• Design and develop your product development, marketing and sales strategies.
• Exploit M&A opportunities by identifying market players with the most innovative pipeline.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
• What’s the next big thing in the diabetes care devices market landscape? – Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the diabetes care devices market and the factors shaping it.

Contents

1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 DIABETES: DISEASE OVERVIEW

2.1 Type 1 Diabetes
2.2 Type 2 Diabetes
2.3 Impaired Glucose Tolerance
2.4 Diabetes Accentuating Cardiovascular Disease
  2.4.1 Atherosclerosis
  2.4.2 Diabetic Cardiomyopathy (DCM)
  2.4.3 Stroke
  2.4.4 Renal Disease
2.5 Diabetes a Burden on Healthcare Spending

3 DIABETES CARE DEVICES MARKET: MARKET CHARACTERIZATION

3.1 Global Diabetes Care Devices Market, Revenue ($m), 2002 – 2009
3.2 Global Diabetes Care Devices Market, Revenue Forecasts ($m), 2009 – 2016
3.3 Diabetes Care Devices, Key Market Trends
  3.3.1 Home Healthcare Driving Growth in the Diabetes Care Devices Market
  3.3.2 Brand Loyalty in Diabetes Care Devices Depends on Innovation and Price
  3.3.3 Low Reimbursement for New Diabetes Care Technologies Restraining the Market
  3.3.4 Drug Stores to Remain the Major Distribution Channels for Diabetes Care Devices
3.4 Diabetes Care Devices: Technological Trends
  3.4.1 Innovation in Diabetes Care Devices Aimed at Enhancing Life of Diabetics
  3.4.2 Continuous Glucose Monitoring (CGM) to Position Itself as a Major Diabetes Monitoring Technology
  3.4.3 Disposable Insulin Pumps to Gain Share over Traditional Insulin Pumps
  3.4.4 Pain Free Glucose Monitoring Devices Will Drive Future Growth in the Diabetes Care Device Market
  3.4.5 The Demand for Pain Free Insulin Delivery Devices is Increasing
  3.4.6 Remote Glucose Monitoring to Bolster Compliance Rate in Diabetics
3.5 Diabetes Care Devices Market Drivers
  3.5.1 New Technologies to Boost Sales in the Future
  3.5.2 Increasing Prevalence of Diabetes to Boost Sales
  3.5.3 The Increasing Aging Population of the World to Increase Patient Population
  3.5.4 Increasing Awareness of Better Diabetes Management
  3.5.5 Lifestyle Changes Bringing About the Increase in Disease Prevalence
3.6 Diabetes Care Devices Market Restraints
  3.6.1 Lack of Affordability and Awareness in Developing Nations
  3.6.2 Lack of Reimbursement for New Technologies
  3.6.3 Low Diagnosis Rate
  3.6.4 Low Patient Compliance
  3.6.5 High Cost Is a Restraint for Insulin Pens and Pumps
  3.6.6 Device Recalls Negatively Affect Physician and Patient Perceptions
  3.6.7 Low Prescription Rates and Limited Storage Facilities in the Developing World Restraining the Diabetes Care Devices Market
3.7 Global Diabetes Care Devices Market, Company Share (%), 2008

4 GLOBAL DIABETES CARE DEVICES MARKET: CROSS-SEGMENT MARKET ANALYSIS AND FORECASTS

4.1 Glucose Monitoring Market
  4.1.1 Global Glucose Monitoring Market, Revenue ($m), 2002 – 2009
  4.1.2 Global Glucose Monitoring Market, Revenue Forecasts ($m), 2009 – 2016
  4.1.3 Glucose Monitoring Market Drivers
  4.1.4 Glucose Monitoring Market Restraints
  4.1.5 Glucose Monitoring Market by Segment
4.2 Insulin Delivery Devices
  4.2.1 Global Insulin Delivery, Revenue ($m), Global, 2002 - 2009
  4.2.2 Global Insulin Delivery, Revenue ($m), Global, 2009 – 2016
  4.2.3 Insulin Delivery Devices Market Drivers
  4.2.4 Insulin Delivery Devices Market Restraints
  4.2.5 Insulin Delivery Devices Market by Segment

5 DIABETES CARE DEVICES: COMPETITIVE LANDSCAPE

5.1 Insulin Delivery Devices Market
  5.1.1 Strategic Product Assessment
  5.1.2 Insulin Delivery Devices, Company Share (%), 2008
5.2 Glucose Monitoring Systems
  5.2.1 Overview
  5.2.2 Strategic Product Assessment
  5.2.3 Glucose Monitoring Systems Company Share (%)
5.3 Key Company Profiles
  5.3.1 F. Hoffmann-La Roche Ltd
  5.3.2 LifeScan (Johnson & Johnson)
  5.3.3 Bayer Healthcare
  5.3.4 Abbott Laboratories
  5.3.5 Becton, Dickinson and Company
  5.3.6 Medtronic
  5.3.7 Novo Nordisk
  5.3.8 Others
  5.3.9 Product Profiles of the Major Marketed Products in the Glucose Monitoring Systems Market
  5.3.10 OneTouch UltraMini
  5.3.11 Contour Meter

6 GLOBAL DIABETES CARE DEVICES MARKET: CROSS-COUNTRY ANALYSIS AND FORECASTS

6.1 Revenue, By Country, 2002 – 2009
  6.1.1 The US Diabetes Care Devices Market, Revenue ($m), 2002 – 2009
  6.1.2 Canada Diabetes Care Devices Market, Revenue ($m), 2002 – 2009
  6.1.3 The UK Diabetes Care Devices Market, Revenue ($m), 2002 – 2009
  6.1.4 Germany Diabetes Care Devices Market, Revenue ($m), 2002 – 2009
  6.1.5 France Diabetes Care Devices Market, Revenue ($m), 2002 – 2009
  6.1.6 Italy Diabetes Care Devices Market, Revenue ($m), 2002 – 2009
  6.1.7 Spain Diabetes Care Devices Market, Revenue ($m), 2002 – 2009
  6.1.8 Japan Diabetes Care Devices Market, Revenue ($m), 2002 – 2009
  6.1.9 China Diabetes Care Devices Market, Revenue ($m), 2002 – 2009
  6.1.10 India Diabetes Care Devices Market, Revenue ($m), 2002 – 2009
  6.1.11 Australia Diabetes Care Devices Market, Revenue ($m), 2002 – 2009
  6.1.12 Brazil Diabetes Care Devices Market, Revenue ($m), 2002 – 2009
6.2 Revenue Forecasts, By Country, 2009 – 2016
  6.2.1 The US Diabetes Care Devices Market, Revenue ($m), 2009 – 2016
  6.2.2 Canada Diabetes Care Devices Market, Revenue ($m), 2009 – 2016
  6.2.3 The UK Diabetes Care Devices Market, Revenue ($m), 2009 – 2016
  6.2.4 Germany Diabetes Care Devices Market, Revenue ($m), 2009 – 2016
  6.2.5 France Diabetes Care Devices Market, Revenue ($m), 2009 – 2016
  6.2.6 Italy Diabetes Care Devices Market, Revenue ($m), 2009 – 2016
  6.2.7 Spain Diabetes Care Devices Market, Revenue ($m), 2009 – 2016
  6.2.8 Japan Diabetes Care Devices Market, Revenue ($m), 2009 – 2016
  6.2.9 China Diabetes Care Devices Market, Revenue ($m), 2009 – 2016
  6.2.10 India Diabetes Care Devices Market, Revenue ($m), 2009 – 2016
  6.2.11 Australia Diabetes Care Devices Market, Revenue ($m), 2009 – 2016
  6.2.12 Brazil Diabetes Care Devices Market, Revenue ($m), 2009 – 2016

7 DIABETES CARE DEVICES: PIPELINE ANALYSIS

7.1 Glucose Monitoring Key Pipeline Products
  7.1.1 Strategic Pipeline Assessment
  7.1.2 Profiles of Promising Devices under Clinical Development
  7.1.3 Glucose Monitoring Systems Pipeline Product Summary by Product Type
  7.1.4 Glucose Monitoring Systems Pipeline Product Summary: Home Glucose Monitoring Systems
  7.1.5 Glucose Monitoring Systems Pipeline Product Summary: Hospital Setting Glucose Monitoring Systems
  7.1.6 Glucose Monitoring Systems Pipeline Product Summary: Both Home and Hospital Setting Glucose Monitoring Systems
7.2 Future Market Competition in Glucose Monitoring Devices
7.3 Global Glucose Monitoring Systems Market: Emerging Companies
  7.3.1 Introduction
7.4 Insulin Delivery Key Pipeline Products
  7.4.1 Overview
  7.4.2 Strategic Pipeline Assessment
  7.4.3 Insulin Delivery Devices – Clinical Pipeline by Mode of Insulin Delivery
7.5 Global Insulin Delivery Devices Pipeline Product Summary
7.6 Insulin Delivery Devices – Promising Devices under Clinical Development
  7.6.1 Closed-loop diabetes management system
  7.6.2 Paradigm Veo System
  7.6.3 Future Market Competition in Insulin Delivery Devices

8 GLOBAL DIABETES CARE DEVICES MARKET: CONSOLIDATION LANDSCAPE

8.1 Deals by Type 2006 – 2009
8.2 Key Mergers and Acquisitions, Diabetes Care Devices, 2006 - 2009
  8.2.1 Bayer HealthCare Completes Acquisition Of iSense
  8.2.2 Ypsomed Holding Acquires 10% Equity Stake In BIONIME
  8.2.3 Mediscience Technology Acquires SensiVida Medical Systems
  8.2.4 Medco Health Solutions Acquires PolyMedica
  8.2.5 Bayer HealthCare Diabetes Care Acquires Metrika

9 APPENDIX

9.1 Methodology
  9.1.1 Secondary Research
  9.1.2 Primary Research
  9.1.3 Models
  9.1.4 Forecasts
  9.1.5 Expert Panels
9.2 Contact Us
9.3 Disclaimer

LIST OF TABLES

Table 1: Prevalence of Impaired Glucose Tolerance, 2030, Global
Table 2: Diabetes Care Devices, Revenue ($m), Global, 2002 – 2009
Table 3: Diabetes Care Devices, Revenue ($m), Global, 2009 – 2016
Table 4: Average Cost of Therapy, Traditional Glucose Meter Vs Continuous Glucose Monitor, 2009
Table 5: Disposable Insulin Pumps, Revenue ($m), US, 2005 – 2009
Table 6: Disposable Insulin Pumps, Revenue ($m), US, 2009 – 2016
Table 7: Non Invasive Glucose Monitoring Products
Table 8: Oral Insulin Delivery Products under Development, 2009
Table 9: Diabetes Mellitus, Estimated Patient Population (‘000’s), 2030
Table 10: Population Over the age of 65 (‘000’s), 2005 – 2010
Table 11: Glucose Monitoring, Revenue ($m), Global, 2002 – 2009
Table 12: Glucose Monitoring, Revenue ($m), Global, 2009 – 2016
Table 13: Blood Glucose Meters, Revenue ($m), Global, 2002 – 2009
Table 14: Blood Glucose Meters, Revenue ($m), Global, 2009 – 2016
Table 15: Blood Glucose Test Strips, Revenue ($m), Global, 2002 – 2009
Table 16: Blood Glucose Test Strips, Revenue ($m), Global, 2009 – 2016
Table 17: Comparison of Insulin Delivery Devices
Table 18: Insulin Delivery, Revenue ($m), Global, 2002 – 2009
Table 19: Insulin Delivery, Revenue ($m), Global, 2009 – 2016
Table 20: Insulin Pumps, Revenue ($m), Global, 2002 – 2009
Table 21: Insulin Pumps, Revenue ($m), Global, 2009 – 2016
Table 22: Insulin Pens, Revenue ($m), Global, 2002 – 2009
Table 23: Insulin Pens, Revenue ($m), Global, 2009 – 2016
Table 24: Insulin Syringes, Revenue ($m), Global 2002 – 2009
Table 25: Insulin Syringes, Revenue ($m), Global 2009 – 2016
Table 26: Diabetes Care Devices Market, Revenue ($m), US, 2002 – 2009
Table 27: Diabetes Care Devices Market, Revenue ($m), Canada, 2002 – 2009
Table 28: Diabetes Care Devices Market, Revenue ($m), UK, 2002 – 2009
Table 29: Diabetes Care Devices Market, Revenue ($m), Germany, 2002 – 2009
Table 30: Diabetes Care Devices Market, Revenue ($m), France, 2002 – 2009
Table 31: Diabetes Care Devices Market, Revenue ($m), Italy, 2002 – 2009
Table 32: Diabetes Care Devices Market, Revenue ($m), Spain, 2002 – 2009
Table 33: Diabetes Care Devices Market, Revenue ($m), Japan, 2002 – 2009
Table 34: Diabetes Care Devices Market, Revenue ($m), China, 2002 – 2009
Table 35: Diabetes Care Devices Market, Revenue ($m), India, 2002 – 2009
Table 36: Diabetes Care Devices Market, Revenue ($m), Australia, 2002 – 2009
Table 37: Diabetes Care Devices Market, Revenue ($m), Brazil, 2002 – 2009
Table 38: Diabetes Care Devices Market, Revenue ($m), US, 2009 – 2016
Table 39: Diabetes Care Devices Market, Revenue ($m), Canada, 2009 – 2016
Table 40: Diabetes Care Devices Market, Revenue ($m), UK, 2009 – 2016
Table 41: Diabetes Care Devices Market, Revenue ($m), Germany, 2009 – 2016
Table 42: Diabetes Care Devices Market, Revenue ($m), France, 2009 – 2016
Table 43: Diabetes Care Devices Market, Revenue ($m), Italy, 2009 – 2016
Table 44: Diabetes Care Devices Market, Revenue ($m), Spain, 2009 – 2016
Table 45: Diabetes Care Devices Market, Revenue ($m), Japan, 2009 – 2016
Table 46: Diabetes Care Devices Market, Revenue ($m), China, 2009 – 2016
Table 47: Diabetes Care Devices Market, Revenue ($m), India, 2009 – 2016
Table 48: Diabetes Care Devices Market, Revenue ($m), Australia, 2009 – 2016
Table 49: Diabetes Care Devices Market, Revenue ($m), Brazil, 2009 – 2016
Table 50: Home Glucose Monitoring Systems Pipeline Product Summary – I
Table 51: Home Glucose Monitoring Systems Pipeline Product Summary - II
Table 52: Hospital Setting Glucose Monitoring System Pipeline Product Summary
Table 53: Home and Hospital Setting Glucose Monitoring Systems Pipeline Product Summary
Table 54: Glucose Monitoring Systems Emerging Companies and Products- I
Table 55: Glucose Monitoring Systems Emerging Companies and Products - II
Table 56: Global Insulin Delivery Devices Pipeline Product Summary
Table 57: Closed-loop diabetes management system, Product Status
Table 58: Closed-loop diabetes management system, Product Description
Table 59: Paradigm Veo System, Product Status
Table 60: Paradigm Veo System, Product Description
Table 61: Deal Volume By Type, Diabetes Care Devices, 2006-2009

LIST OF FIGURES

Figure 1: Diabetes Care Devices, Revenue ($m), Global, 2002 – 2009
Figure 2: Diabetes Care Devices, Revenue ($m), Global, 2009 – 2016
Figure 3: Glucose Monitoring Devices, Distribution Channel Share (%), 2008
Figure 4: Insulin Delivery, Distribution Channel Share (%), 2008
Figure 5: Disposable Insulin Pumps, Revenue ($m), US, 2005 – 2009
Figure 6: Disposable Insulin Pumps, Revenue ($m), US, 2009 – 2016
Figure 7: Diabetes Care Devices, Global, Company Share (% in Revenue), 2008
Figure 8: Glucose Monitoring, Revenue ($m), Global, 2002 – 2009
Figure 9: Glucose Monitoring, Revenue ($m), Global, 2009 – 2016
Figure 10: Blood Glucose Meters, Revenue ($m), Global, 2002 – 2009
Figure 11: Blood Glucose Meters, Revenue ($m), Global, 2009 – 2016
Figure 12: Blood Glucose Test Strips, Revenue ($m), Global, 2002 – 2009
Figure 13: Blood Glucose Test Strips, Revenue ($m), Global, 2009 – 2016
Figure 14: Insulin Delivery, Revenue ($m), Global, 2002 – 2009
Figure 15: Insulin Delivery, Revenue ($m), Global, 2009 – 2016
Figure 16: Insulin Pumps, Revenue ($m), Global, 2002 – 2009
Figure 17: Insulin Pumps, Revenue ($m), Global, 2009 – 2016
Figure 18: Insulin Pens, Revenue ($m), Global, 2002 – 2009
Figure 19: Insulin Pens, Revenue ($m), Global, 2009 – 2016
Figure 20: Insulin Syringes, Revenue ($m), Global 2002 – 2009
Figure 21: Insulin Syringes, Revenue ($m), Global 2009 – 2016
Figure 22: Key Insulin Delivery Devices: Strategic Product Assessment
Figure 23: Insulin Delivery Devices, Company Share (% in Revenues), 2008
Figure 24: Glucose Monitoring Systems: Strategic Product Assessment
Figure 25: Glucose Monitoring Systems, Company Share (% in Revenues), 2008
Figure 26: Diabetes Care Devices Market, Revenue ($m), US, 2002 – 2009
Figure 27: Diabetes Care Devices Market, Revenue ($m), Canada, 2002 – 2009
Figure 28: Diabetes Care Devices Market, Revenue ($m), UK, 2002 – 2009
Figure 29: Diabetes Care Devices Market, Revenue ($m), Germany, 2002 – 2009
Figure 30: Diabetes Care Devices Market, Revenue ($m), France, 2002 – 2009
Figure 31: Diabetes Care Devices Market, Revenue ($m), Italy, 2002 – 2009
Figure 32: Diabetes Care Devices Market, Revenue ($m), Spain, 2002 – 2009
Figure 33: Diabetes Care Devices Market, Revenue ($m), Japan, 2002 – 2009
Figure 34: Diabetes Care Devices Market, Revenue ($m), China, 2002 – 2009
Figure 35: Diabetes Care Devices Market, Revenue ($m), India, 2002 – 2009
Figure 36: Diabetes Care Devices Market, Revenue ($m), Australia, 2002 – 2009
Figure 37: Diabetes Care Devices Market, Revenue ($m), Brazil, 2002 – 2009
Figure 38: Diabetes Care Devices Market, Revenue ($m), US, 2009 – 2016
Figure 39: Diabetes Care Devices Market, Revenue ($m), Canada, 2009 – 2016
Figure 40: Diabetes Care Devices Market, Revenue ($m), UK, 2009 – 2016
Figure 41: Diabetes Care Devices Market, Revenue ($m), Germany, 2009 – 2016
Figure 42: Diabetes Care Devices Market, Revenue ($m), France, 2009 – 2016
Figure 43: Diabetes Care Devices Market, Revenue ($m), Italy, 2009 – 2016
Figure 44: Diabetes Care Devices Market, Revenue ($m), Spain, 2009 – 2016
Figure 45: Diabetes Care Devices Market, Revenue ($m), Japan, 2009 – 2016
Figure 46: Diabetes Care Devices Market, Revenue ($m), China, 2009 – 2016
Figure 47: Diabetes Care Devices Market, Revenue ($m), India, 2009 – 2016
Figure 48: Diabetes Care Devices Market, Revenue ($m), Australia, 2009 – 2016
Figure 49: Diabetes Care Devices Market, Revenue ($m), Brazil, 2009 – 2016
Figure 50: Distribution of Pipeline Products by Stage of Development, Glucose Monitoring
Figure 51: Glucose Monitoring Systems Pipeline Product by Product Type
Figure 52:The Glucose Monitoring Competitive Landscape to Witness a Price War
Figure 53: Distribution of Pipeline Products by Stage of Development, Insulin Delivery
Figure 54: Insulin Delivery Devices – Clinical Pipeline by Mode of Insulin Delivery
Figure 55: The Insulin Delivery Competitive Landscape to Witness a Race to Capture Unmet Need
Figure 56: Deal Volume By Type, Global Diabetes Care Devices, 2006-2009
Figure 57: GBI Research Methodology

COMPANIES MENTIONED

F. Hoffmann-La Roche Ltd
LifeScan (Johnson & Johnson)
Bayer Healthcare
Abbott Laboratories
Becton, Dickinson and Company
Medtronic
Novo Nordisk Skip to top